SLU-PP-332 5MG

SLU-PP-332 5mg — Estrogen-Related Receptor Agonist Research Compound

SLU-PP-332 5mg is a small-molecule research compound identified as a pan-agonist of the estrogen-related receptor (ERR) family, which includes ERRalpha, ERRbeta, and ERRgamma. These orphan nuclear receptors are central regulators of mitochondrial biogenesis, oxidative metabolism, and energy expenditure in metabolically active tissues. SLU-PP-332 has attracted significant research interest as a pharmacological exercise mimetic tool for investigating ERR-driven metabolic adaptations.

Research Applications

Research using SLU-PP-332 has investigated ERR nuclear receptor pathway activation and downstream effects on mitochondrial gene expression programs, fatty acid oxidation, and skeletal muscle metabolic switching. Studies in preclinical models have examined its ability to replicate aspects of exercise-induced metabolic adaptation, including increased mitochondrial density, enhanced oxidative phosphorylation capacity, and upregulation of PGC-1alpha transcriptional targets, positioning it as a valuable tool in exercise physiology and energy metabolism research.

Formulation & Purity

Supplied as a high-purity solid preparation, this product exceeds >99% purity as verified by HPLC analysis. Researchers should dissolve this compound in a suitable carrier solvent such as DMSO and store according to conditions appropriate for small-molecule stability, protected from light and moisture.

Intended Use

SLU-PP-332 5mg is intended exclusively for in vitro and non-clinical scientific research. It is not approved for human or animal therapeutic, diagnostic, or medicinal use. All handling and experimentation must be conducted by trained professionals within appropriate controlled laboratory environments.

Ultima Labs